secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-325825
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharmaceuticals secures additional $68.5M PIPE from TCGX ahead of Bluejay acquisition
--------------------------------------------------------------------------------

- 1,000,000 shares at $68.48/share; ~$68.5M gross proceeds from TCGX.
- Combined with Dec 2025 $200M PIPE raises total ~$268.5M to fund Bluejay acquisition.
- Both PIPE and Bluejay acquisition expected to close in Q1 2026, subject to conditions.
- Registration rights agreement provides for resale registration of the PIPE shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312525325825/0001193125-25-325825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312525325825/d53644d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-325825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer